Suppr超能文献

血小板活化因子及其在创伤、休克和脓毒症中的作用。

Platelet activating factor and its role in trauma, shock, and sepsis.

作者信息

Ayala A, Chaudry I H

机构信息

Department of Surgery, Michigan State University, East Lansing, USA.

出版信息

New Horiz. 1996 May;4(2):265-75.

PMID:8774801
Abstract

Platelet activating factor (PAF) is a phospholipid mediator released upon stimulation of cells, such as mast cells, basophils, neutrophils, and macrophages, by opsonized agents. This mediator produces a variety of biological effects and acts via specific binding sites present on various cell types. This article briefly reviews the nature of PAF, as well as what is understood about its role in the inflammatory response associated with trauma, shock, and sepsis. Much of what is known of PAF biology and experimental pathophysiology has come from the discovery and subsequent use of selective PAF antagonists. In this respect, several of the PAF antagonists have been examined experimentally and some have been tested clinically in patients with sepsis and septic shock. Experimental and clinical studies suggest that PAF antagonists appear to be effective in cases of severe Gram-negative septic shock. Nonetheless, this mediator may not be a major component involved in the systemic inflammatory response syndrome.

摘要

血小板活化因子(PAF)是一种磷脂介质,在调理素化因子刺激细胞(如肥大细胞、嗜碱性粒细胞、中性粒细胞和巨噬细胞)时释放。这种介质会产生多种生物学效应,并通过存在于各种细胞类型上的特异性结合位点发挥作用。本文简要回顾了PAF的性质,以及目前对其在与创伤、休克和脓毒症相关的炎症反应中所起作用的了解。关于PAF生物学和实验病理生理学的许多知识都来自于选择性PAF拮抗剂的发现及后续应用。在这方面,几种PAF拮抗剂已进行了实验研究,一些已在脓毒症和感染性休克患者中进行了临床测试。实验和临床研究表明,PAF拮抗剂在严重革兰氏阴性菌感染性休克病例中似乎有效。尽管如此,这种介质可能不是全身炎症反应综合征的主要组成部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验